25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EMBT (Ember Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ember Therapeutics Inc together

I guess you are interested in Ember Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Ember Therapeutics Incโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Ember Therapeutics Incโ€™s Price Targets

I'm going to help you getting a better view of Ember Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ember Therapeutics Inc

I send you an email if I find something interesting about Ember Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Ember Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Ember Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.01
How sure are you?
0.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-2,324.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ember Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00

2.2. Growth of Ember Therapeutics Inc (5 min.)




Is Ember Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$238.4k-$215.2k-$23.2k-9.7%

How much money is Ember Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$23.2k-$16.3k-$6.9k-29.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Ember Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ember Therapeutics Inc?

Welcome investor! Ember Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Ember Therapeutics Inc.

First you should know what it really means to hold a share of Ember Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Ember Therapeutics Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ember Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ember Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ember Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-581.1%0.00-581.1%0.00-408.3%0.00-436.4%0.00-436.4%0.00-436.4%
Usd Book Value Change Per Share0.00-581.1%0.00-581.1%0.00-408.3%0.00-1,987.3%0.00-1,987.3%0.00-1,987.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-581.1%0.00-581.1%0.00-408.3%0.00-1,987.3%0.00-1,987.3%0.00-1,987.3%
Usd Price Per Share0.00-0.00-0.00-0.00-0.00-0.00-
Price to Earnings Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-5,810.50-19,872.50
Gains per Year (10000000 shares)-23,242.00-79,490.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-23242-232520-79490-79500
20-46484-464940-158980-158990
30-69726-697360-238470-238480
40-92968-929780-317960-317970
50-116210-1162200-397450-397460
60-139452-1394620-476940-476950
70-162694-1627040-556430-556440
80-185936-1859460-635920-635930
90-209178-2091880-715410-715420
100-232420-2324300-794900-794910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ember Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-30%-0.002+242%-0.002+242%-0.002+242%
Book Value Per Share---0.006-0.0060%-0.005-10%-0.005-9%-0.005-9%-0.005-9%
Current Ratio--0.0010.0010%0.006-87%0.006-87%0.006-87%0.006-87%
Debt To Asset Ratio--1297.0331297.0330%172.496+652%518.461+150%518.461+150%518.461+150%
Debt To Equity Ratio----0%-0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%-0%
Eps---0.001-0.0010%0.000-30%0.000-25%0.000-25%0.000-25%
Free Cash Flow Per Share--0.0000.0000%-0.001+35%0.000-12%0.000-12%0.000-12%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000+2%0.000-122%0.000-122%0.000-122%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Market Cap4000.000+100%--0%-0%-0%-0%-0%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio-0.0170%--0%-0%-0%-0%-0%
Pe Ratio-0.1720%--0%-0%-0%-0%-0%
Price Per Share0.000+100%--0%-0%-0%-0%-0%
Price To Free Cash Flow Ratio-0.2390%--0%-0%-0%-0%-0%
Quick Ratio--0.0010.0010%0.006-87%0.006-87%0.006-87%0.006-87%
Return On Assets---126.315-126.3150%-13.014-90%-48.262-62%-48.262-62%-48.262-62%
Return On Equity----0%-0%-0%-0%-0%
Total Gains Per Share---0.001-0.0010%0.000-30%-0.002+242%-0.002+242%-0.002+242%
Usd Book Value---238470.000-238470.0000%-215228.000-10%-217531.333-9%-217531.333-9%-217531.333-9%
Usd Book Value Change Per Share---0.001-0.0010%0.000-30%-0.002+242%-0.002+242%-0.002+242%
Usd Book Value Per Share---0.006-0.0060%-0.005-10%-0.005-9%-0.005-9%-0.005-9%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Eps---0.001-0.0010%0.000-30%0.000-25%0.000-25%0.000-25%
Usd Free Cash Flow---16721.000-16721.0000%-22590.000+35%-14706.000-12%-14706.000-12%-14706.000-12%
Usd Free Cash Flow Per Share--0.0000.0000%-0.001+35%0.000-12%0.000-12%0.000-12%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000+2%0.000-122%0.000-122%0.000-122%
Usd Market Cap4000.000+100%--0%-0%-0%-0%-0%
Usd Price Per Share0.000+100%--0%-0%-0%-0%-0%
Usd Profit---23242.000-23242.0000%-16333.000-30%-17454.000-25%-17454.000-25%-17454.000-25%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.001-0.0010%0.000-30%-0.002+242%-0.002+242%-0.002+242%
 EOD+3 -1MRQTTM+0 -0YOY+5 -143Y+4 -155Y+4 -1510Y+4 -15

3.3 Fundamental Score

Let's check the fundamental score of Ember Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.172
Price to Book Ratio (EOD)Between0-1-0.017
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.001
Debt to Asset Ratio (MRQ)Less than11,297.033
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-126.315
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Ember Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Ember Therapeutics Inc

Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company focuses on the clinical application of bone morphogenetic protein-7 (BMP-7) to develop regenerative medicines for the disease modification of osteoarthritis (OA), reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases, such as chronic kidney disease (CKD) and Alport's syndrome, as well as metabolic diseases, including obesity and type 2 diabetes. Its lead BMP-7 product candidates include MT-006, which has completed Phase 2a clinical trial for targeting OA; MT-007 that has completed Preclinical trial for CKD and Alport syndrome; MT-008, a Preclinical trial completed candidate for Alport syndrome; and MT-009, a Preclinical trial completed candidate for metabolic disease. The company also holds approximately 450 patents covering BMP-7 and its related family of BMPs, variants, novel formulations, delivery technologies, associated clinical data, and manufactured material with current good manufacturing practice. Ember Therapeutics, Inc. was founded in 2010 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-06-07 06:14:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Ember Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • A Net Profit Margin of 0.0%ย means thatย $0.00 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ember Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--94.6%+94.6%
TTM--144.8%+144.8%
YOY--198.4%+198.4%
3Y--256.0%+256.0%
5Y--348.5%+348.5%
10Y--479.9%+479.9%
4.3.1.2. Return on Assets

Shows howย efficientย Ember Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • -12,631.5% Return on Assets means thatย Ember Therapeutics Inc generatedย $-126.32 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ember Therapeutics Inc:

  • The MRQ is -12,631.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12,631.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12,631.5%TTM-12,631.5%0.0%
TTM-12,631.5%YOY-1,301.4%-11,330.1%
TTM-12,631.5%5Y-4,826.2%-7,805.4%
5Y-4,826.2%10Y-4,826.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12,631.5%-11.4%-12,620.1%
TTM-12,631.5%-11.4%-12,620.1%
YOY-1,301.4%-11.2%-1,290.2%
3Y-4,826.2%-11.7%-4,814.5%
5Y-4,826.2%-11.9%-4,814.3%
10Y-4,826.2%-13.8%-4,812.4%
4.3.1.3. Return on Equity

Shows how efficient Ember Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • 0.0% Return on Equity means Ember Therapeutics Inc generated $0.00ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ember Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.3%+13.3%
TTM--14.5%+14.5%
YOY--14.3%+14.3%
3Y--16.9%+16.9%
5Y--17.2%+17.2%
10Y--19.9%+19.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ember Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Ember Therapeutics Inc is operatingย .

  • Measures how much profit Ember Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • An Operating Margin of 0.0%ย means the company generated $0.00 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ember Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--252.1%+252.1%
YOY--210.7%+210.7%
3Y--220.1%+220.1%
5Y--351.8%+351.8%
10Y--449.6%+449.6%
4.3.2.2. Operating Ratio

Measures how efficient Ember Therapeutics Inc is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ember Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM-2.737-2.737
YOY-3.107-3.107
3Y-3.655-3.655
5Y-4.745-4.745
10Y-6.397-6.397
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ember Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ember Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Biotechnology industry mean).
  • A Current Ratio of 0.00ย means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ember Therapeutics Inc:

  • The MRQ is 0.001. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.001. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.006-0.005
TTM0.0015Y0.006-0.005
5Y0.00610Y0.0060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0013.616-3.615
TTM0.0013.745-3.744
YOY0.0064.149-4.143
3Y0.0064.628-4.622
5Y0.0065.766-5.760
10Y0.0066.150-6.144
4.4.3.2. Quick Ratio

Measures if Ember Therapeutics Inc is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • A Quick Ratio of 0.00ย means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ember Therapeutics Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.006-0.005
TTM0.0015Y0.006-0.005
5Y0.00610Y0.0060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0012.891-2.890
TTM0.0013.143-3.142
YOY0.0063.843-3.837
3Y0.0064.308-4.302
5Y0.0065.702-5.696
10Y0.0066.505-6.499
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ember Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Ember Therapeutics Incย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Ember Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1,297.03ย means that Ember Therapeutics Inc assets areย financed with 129,703.3% credit (debt) and the remaining percentage (100% - 129,703.3%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Ember Therapeutics Inc:

  • The MRQ is 1,297.033. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1,297.033. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1,297.033TTM1,297.0330.000
TTM1,297.033YOY172.496+1,124.536
TTM1,297.0335Y518.461+778.572
5Y518.46110Y518.4610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,297.0330.339+1,296.694
TTM1,297.0330.356+1,296.677
YOY172.4960.335+172.161
3Y518.4610.339+518.122
5Y518.4610.349+518.112
10Y518.4610.382+518.079
4.5.4.2. Debt to Equity Ratio

Measures ifย Ember Therapeutics Inc is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ember Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.387-0.387
TTM-0.438-0.438
YOY-0.414-0.414
3Y-0.455-0.455
5Y-0.464-0.464
10Y-0.504-0.504
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Ember Therapeutics Inc generates.

  • Above 15 is considered overpriced butย always compareย Ember Therapeutics Inc to theย Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ember Therapeutics Inc:

  • The EOD is -0.172. Based on the earnings, the company is expensive. -2
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-0.172MRQ--0.172
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.172-2.145+1.973
MRQ--2.030+2.030
TTM--2.526+2.526
YOY--3.682+3.682
3Y--3.711+3.711
5Y--6.083+6.083
10Y--6.715+6.715
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ember Therapeutics Inc:

  • The EOD is -0.239. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-0.239MRQ--0.239
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.239-2.986+2.747
MRQ--2.697+2.697
TTM--3.653+3.653
YOY--4.430+4.430
3Y--5.157+5.157
5Y--8.483+8.483
10Y--9.320+9.320
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Ember Therapeutics Inc is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ember Therapeutics Inc:

  • The EOD is -0.017. Based on the equity, the company is expensive. -2
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-0.017MRQ--0.017
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0172.023-2.040
MRQ-1.855-1.855
TTM-2.173-2.173
YOY-2.479-2.479
3Y-2.589-2.589
5Y-3.728-3.728
10Y-4.370-4.370
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2014-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets0
Total Liabilities239
Total Stockholder Equity-238
 As reported
Total Liabilities 239
Total Stockholder Equity+ -238
Total Assets = 0

Assets

Total Assets0
Total Current Assets0
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 0
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities239
Long-term Liabilities0
Total Stockholder Equity-238
Total Current Liabilities
Short-term Debt 201
Accounts payable 4
Other Current Liabilities 34
Total Current Liabilities  (as reported)239
Total Current Liabilities  (calculated)239
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -2,919
Other Stockholders Equity 2,677
Total Stockholder Equity (as reported)-238
Total Stockholder Equity (calculated)-238
+/-0
Other
Cash and Short Term Investments 0
Common Stock Shares Outstanding 3,708
Liabilities and Stockholders Equity 0
Net Debt 200
Net Tangible Assets -238
Net Working Capital -238
Short Long Term Debt Total 201



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2014-12-312013-12-312012-12-31
> Total Assets 
2
1
0
012
   > Total Current Assets 
2
1
0
012
       Cash And Cash Equivalents 
2
1
0
012
   > Long-term Assets 000
> Total Liabilities 
201
216
239
239216201
   > Total Current Liabilities 
201
216
239
239216201
       Short-term Debt 
163
185
201
201185163
       Accounts payable 
15
3
4
4315
       Other Current Liabilities 
23
28
34
342823
   > Long-term Liabilities 000
> Total Stockholder Equity
-199
-215
-238
-238-215-199
   Common Stock
4
4
4
444
   Retained Earnings -2,919-2,896-2,879
   Capital Surplus 000
   Treasury Stock000
   Other Stockholders Equity 
2,677
2,677
2,677
2,6772,6772,677



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2014-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-17
Operating Income-17-17
 
Operating Expense (+$)
Research Development0
Selling General Administrative17
Selling And Marketing Expenses0
Operating Expense1717
 
Net Interest Income (+$)
Interest Income0
Interest Expense-6
Other Finance Cost-6
Net Interest Income0
 
Pretax Income (+$)
Operating Income-17
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23-12
EBIT - interestExpense = -23
-23
-17
Interest Expense6
Earnings Before Interest and Taxes (EBIT)-17-17
Earnings Before Interest and Taxes (EBITDA)-17
 
After tax Income (+$)
Income Before Tax-23
Tax Provision-0
Net Income From Continuing Ops-23-23
Net Income-23
Net Income Applicable To Common Shares-23
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring6
Other Operating Expenses17
Total Other Income/Expenses Net-60
 

Technical Analysis of Ember Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ember Therapeutics Inc. The general trend of Ember Therapeutics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ember Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ember Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ember Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Know someone who trades $EMBT? Share this with them.๐Ÿ‘‡

Ember Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ember Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ember Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartEmber Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ember Therapeutics Inc. The current adx is .

Ember Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Relative Strength Index (RSI) ChartEmber Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Stochastic Oscillator ChartEmber Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Commodity Channel Index (CCI) ChartEmber Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartEmber Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Williams %R ChartEmber Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Average True Range (ATR) ChartEmber Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily On-Balance Volume (OBV) ChartEmber Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ember Therapeutics Inc.

Ember Therapeutics Inc Daily Money Flow Index (MFI) ChartEmber Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ember Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Ember Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ember Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ember Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Ember Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ember Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ember Therapeutics Inc

I send you an email if I find something interesting about Ember Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ember Therapeutics Inc.

Receive notifications about Ember Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.